[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.112.64. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
September 13, 2006

Drug Ad Moratorium?

JAMA. 2006;296(10):1225. doi:10.1001/jama.296.10.1225-a

A 2-year moratorium on direct-to-consumer advertising for some newly approved drugs is part of a bipartisan bill introduced in the Senate intended to increase prescription medication safety. The bill (S 3807; http://thomas.loc.gov) also calls on pharmaceutical manufacturers to conduct better safety planning before a drug receives approval from the Food and Drug Administration. The government agency would also have to improve its postmarketing surveillance.

First Page Preview View Large
First page PDF preview
First page PDF preview
×